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Abstract
Background: Endotoxins are ubiquitously present in the environment and constitute a significant component of
ambient air. These substances have been shown to modulate the allergic response, however a consensus has yet
to be reached whether they attenuate or exacerbate asthmatic responses. The current investigation examined
whether reducing the concentration of lipopolysaccharide (LPS) in a house dust extract (HDE) containing high
concentrations of both cockroach allergens [1] and LPS would attenuate asthma-like pulmonary inflammation.
Methods: Mice were sensitized with CRA and challenged with the intact HDE, containing 182 ng of LPS, or an
LPS-reduced HDE containing 3 ng LPS, but an equivalent amount of CRA. Multiple parameters of asthma-like
pulmonary inflammation were measured.
Results: Compared to HDE challenged mice, the LPS-reduced HDE challenged mice had significantly reduced
TNFa levels in the bronchoalveolar lavage fluid. Plasma levels of IgE and IgG1 were significantly reduced, however
no change in CRA-specific IgE was detected. In HDE mice, plasma IgG2a levels were similar to naïve mice, while
LPS-reduced HDE mice had significantly greater concentrations. Reduced levels of LPS in the HDE did not decrease
eosinophil or neutrophil recruitment into the alveolar space. Equivalent inflammatory cell recruitment occurred
despite having generally higher pulmonary concentrations of eotaxins and CXC chemokines in the LPS-reduced
HDE group. LPS-reduced HDE challenge induced significantly higher concentrations of IFNg, and IL-5 and IL-13 in
the BAL fluid, but did not decrease airways hyperresponsiveness or airway resistance to methacholine challenge.
Conclusion: These data show that reduction of LPS levels in the HDE does not significantly protect against the
severity of asthma-like pulmonary inflammation.
Background
Asthma is a chronic allergic disorder characterized by
IgE production, airway eosinophilia and bronchial
hyperresponsiveness [2]. Numerous studies have shown
that allergens are not solely responsible for the severity
of the asthmatic response (reviewed in [3]). Microbial
components, such as lipopolysaccharide (LPS) from
Gram negative bacteria, are ubiquitously present in the
environment, including the ambient air. In addition to
being potent activators of innate immunity, these com-
pounds have been shown to modulate asthma severity
[4]. The presence of microbial components often is
associated with environmental and household cleanli-
ness, however the hygiene hypothesis postulates that the
lack of exposure to these pathogens at a young age
increases susceptibility to allergen sensitization, account-
ing for the dramatic increases in allergic diseases in the
developed world [5,6].
Several studies have been carried out investigating the
role LPS plays in allergen sensitization. These studies
suggest that in ovalbumin (OVA) models, increasing
doses of LPS protect against eosinophilia and AHR [7,8].
Recently, more evidence has emerged implicating
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the mechanism responsible for this protection. Eisen-
barth. et. al. showed that OVA sensitization in toll-like
receptor-4 (TLR4) deficient mice did not result in IgE
production or eosinophil recruitment, however these
responses could be restored by exogenous administra-
tion of TNFa shortly after sensitization [8]. Additionally,
mice deficient in TNF-receptor associated factor-1 do
not develop eosinophilia or AHR in response to OVA
sensitization and challenge [9].
While LPS plays a key role in allergen sensitization,
the synergistic effect of LPS and allergen during the
effector phase of asthma remains unclear. We sought to
determine whether the removal of LPS from house dust
obtained from the home environment can protect
against the severity of murine airways-inflammation. We
employed a clinically relevant model of asthma-like pul-
monary inflammation based on immunization with a
CRA [1] extract containing LPS, followed by challenge
with a house dust extract (HDE) collected from the
home of an asthmatic child. This HDE contains high
levels of both CRA and LPS, and can induce the cardi-
nal features of asthma-like inflammation, such as airway
eosinophilia, airways hyperresponsiveness and IgE pro-
duction [10,11]. In order to investigate the role of LPS
at the time of allergen challenge, LPS was removed from
the HDE using a commercially available column. The
current study shows that reduction of the LPS content
in the HDE exacerbates cytokine production, reduces
IgE, but does not alter AHR, airway eosinophilia or neu-
trophil recruitment.
Methods
Animals
Female BALB/c mice 9-12 weeks old were purchased
from Jackson Laboratories (Bar Harbor, ME) and main-
tained under standard laboratory conditions. The mice
were housed in a temperature and humidity controlled
room with 12 hour light/dark cycles. Food and water
were allowed ad libitum. All experiments were per-
formed according to the National Institutes of Health
guidelines and were approved by the Boston University
and University of Michigan Institutional Animal Care
and Use Committees.
Reduction of LPS content in House Dust Extract
LPS was removed from the house dust extract (HDE)
using the EndoTrap Blue column (Profos AG, Regens-
burg, Germany), by modifying the manufacturer’s proto-
col. HDE was diluted 1:1 in sterile PBS. The depletion
column was equilibrated with the provided equilibration
buffer modified to contain 400 mM NaCl. The HDE
mixture was applied to the column and eluted using the
provided elution buffer. The eluted mixture was
immediately aliquoted and stored at -70°C until use.
Concentrations of Bla g (Blatella germanica)1a n dB l a
g2 and LPS were measured after application to the col-
umn, and appropriate dilutions prepared for in vivo
administration.
LPS Assay
LPS in the house dust extract and cockroach allergen
preparations was assayed in pyrogen free water using
the endpoint Limulus amoebocyte lysate (LAL) assay
(Lonza, Basel Switzerland, 50-647 U). 96-well micro-
plates and substrate solutions were warmed to 37°C.
50 μL of sample and standard were added to the plate
in duplicate followed by 50 μLL A Lr e g e n t .T h ep l a t e
was incubated at 37°C for 10 min. 100 μLo fs u b s t r a t e
solution was then added to each well and the plate was
incubated at 37°C for 6 minutes. The reaction was
stopped with 50 μL 25% glacial acetic acid and the
absorbance was read at 405 nm.
Asthma induction protocol
House dust collection and processing was performed as
previously described [11]. We used a commercial CRA
preparation for immunizations since there are limited
amounts of HDE available. Additionally, our lab has
demonstrated that asthma-like inflammation induced by
the HDE is CRA specific [12] and CRA administration
will produce asthma-like pulmonary inflammation
[13,14]. For these reasons, the commercial German
cockroach-allergen [1] (Greer Laboratories, LeNoir, NC,
Item # B46) was used for immunization [12]. The CRA
(61.9 ng) was diluted to a final volume of 50 μLi ns t e r -
ile phosphate buffered saline (PBS) immediately prior to
use. This mixture was emulsified in 50 μLT i t e r M a x
Gold adjuvant (CytRx, Norcross, GA). Each mouse was
injected i.p. with 100 μL of the adjuvant/allergen mix-
ture on day 0. On day 14 and day 21, mice were chal-
lenged by direct intratracheal installation of 50 μLo f
the intact HDE or LPS-reduced HDE, each containing
61.9 ng CRA [15]. Briefly, mice were lightly anesthetized
and suspended by their front incisors on a vertical
board. Their tails were taped down to support the body
weight. The tongue was gently extended and the liquid
was placed at the base of the oropharynx so that it was
inhaled.
Timepoints for data collection
Animals were euthanized by cervical dislocation follow-
ing ketamine/xylazine anesthesia at 0, 2 or 24 hours
post final allergen challenge. At the time of sacrifice,
plasma, bronchoalveolar lavage, and lung homogenates
were prepared. The 2 and 24 hour timepoints represent
the early phase and late phase of the asthmatic response
based on prior publications [11]. The 0 hour timepoint
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the second pulmonary challenge. This timepoint was
included to determine if sensitization and the first chal-
lenge caused any lasting inflammatory reaction in either
group. Airway hyperresponsiveness [10] was measured
4 hours post final challenge, based on our observations
of robust AHR induction at this timepoint (data not
shown). These mice were then sacrificed at 24 hours.
Airways Hyperresponsiveness and Airway Resistance
Airways changes were measured either with direct inva-
sive techniques (Flexivent, Scireq Scientific Respiratory
Equipment, Montreal, Canada) or using unrestrained
whole body plethysmography (Buxco Systems, Troy,
NY). For whole body plethysmography, mice were
placed in the instrument chamber and allowed to accli-
mate for at least 5 minutes. Baseline measurements
were recorded for 5 minutes. Mice were then challenged
for 2 minutes with aerosolized PBS and increasing doses
of methacholine (Sigma, St. Louis, MO). Each aerosol
challenge was followed by 5 minutes of monitoring and
data collection. The partial pressure difference between
the experimental and reference chambers represented
the PenH parameter, and the data presented as the per-
cent increase above baseline PenH measurements.
These data were further verified using invasive pul-
monary function tests. For measurement of mouse air-
way resistance, mice were anesthetized with an i.p.
injection of 1:5 diluted pentobarbital (Nembutal
®,0 . 0 1 6
ml/g body weight, Ovation Pharmaceutical, Deerfield,
IL). The paralytic was pancuronium (Sigma-Aldrich, St.
Louis, MO) at 0.5 micrograms per gram body weight.
Once adequate surgical sedation was established, deter-
mined by a firm squeeze of the foot pad, a tracheotomy
was performed by insertion of an 18 g polyethylene can-
nula into the distal trachea. The mouse was then placed
on the FlexiVent mechanical ventilator (Scireq Scientific
Respiratory Equipment, Montreal, Canada) and venti-
lated at 190 breaths per minute with positive-end
expiratory pressure set at 3 cmH2O. Measurement of
airway resistance in response to increasing concentra-
tions of aerosolized methacholine was obtained through
periodic computer-generated “snapshot 150” forced-
maneuver interruptions in ventilation. Data are then
presented as resistance change from baseline (cmH2O
per milliliter per second).
Bronchoalveolar lavage and lung homogenate
preparation
Mice were exanguinated and BAL performed by cannu-
lating the trachea. The lung was lavaged with 2, 1 mL
aliquots of warm Hank’s Buffered Salt Solution (HBSS,
Gibco, Grand Island, NY). Both aliquots were centri-
fuged and the supernatant of the first wash removed
and frozen at -20°C for cytokine analysis. The superna-
tant from the second aliquot was discarded and the cell
pellets were resuspended and combined. Total cell
counts were obtained using a Beckman-Coulter particle
counter model ZF (Coulter Electronics Inc., Hialeah,
FL). Cytospin preparations were stained with Diff-Quick
and 300 cell differential counts were performed to deter-
mine the absolute numbers of inflammatory cells. The
right lung was removed, placed in ice cold protease inhi-
bitor cocktail (Roche, Indianapolis, IN) containing
0.00005% Triton X-100 in PBS, and homogenized with
3, 10 second passes in a Brinkmann Polytron PT3000
homogenizer. An aliquot was removed and sonicated in
hexadecyltrimethylammonium bromide (HTAB) buffer
for myeloperoxidase assay. A separate aliquot was
removed and sonicated in 0.5% cetyltrimethylammo-
niumchloride (CTAC) (Sigma, St. Louis, MO) for eosi-
nophil-specific peroxidase assay. The homogenized and
sonicated mixtures were centrifuged at 15,000 g for
15 min. The homogenate supernatant was removed and
stored at -20°C for cytokine analysis and the supernatant
from the sonicated fractions was used immediately for
peroxidase assays.
Myeloperoxidase and Eosinophil Peroxidase Assays
Myeloperoxidase (MPO) and eosinophil peroxidase
(EPO) assays were performed as described previously
[16], with some modifications. EPO was performed by
diluting the supernatant of the mixture sonicated in
CTAC 1:3 in 10 mM HEPES, pH 8, in quadruplicate in
a 96-well plate. 150 μL ice cold stop solution (4N
H2SO4 + 2 mM resorcinol) was added to 2 of the sam-
ple wells. 75 μL of substrate solution containing 6 mM
KBr, 1.5 mM o-phenylenediamine (Sigma, St. Louis,
MO, P9029), and 0.3% H2O2 in 50 mM HEPES, pH8,
was added to the two remaining sample wells and incu-
bated in the dark for 30 seconds. 150 μLi c ec o l ds t o p
solution was added and the absorbance read at 490 nm.
MPO was measured by diluting the supernatant of the
mixture sonicated in HTAB 1:5 in 10 mM citrate buffer,
pH 5 in quadruplicate. 150 μL ice cold stop solution (4N
H2SO4) was added to 2 of the sample wells. 75 μLs u b -
strate solution containing 0.3 mM 3,3’,5,5’-Tetramethyl-
benzidine, 120 mM resorcinol (an eosinophil peroxidase
inhibitor), and 0.007% H2O2 in ddH2Ow a sa d d e dt ot h e
two remaining sample wells and incubated in the dark
for 2 minutes. 150 μL ice cold stop solution was added
and the absorbance read at 450 nm. Data is expressed as
ΔOD reflecting the difference in absorbance between the
average of the sample and background wells.
ELISA
Cytokines and chemokines were measured by ELISA as
previously described [17]. Matched antibody pairs and
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tems (Minneapolis, MN). Lung homogenate samples
were assayed with the addition of 20% normal lung
homogenate to the standards to adjust for the increased
background caused by non-specific matrix effects. Anti-
body ELISA reagents (IgG and IgE) were purchased
from Bethyl Laboratories (Montgomery, TX) and assays
were performed by the same standard protocols as for
cytokines and chemokines. Cockroach allergen ELISAs
were performed as previously described [12] with anti-
body pairs and recombinant standards from Indoor Bio-
technologies (Charlottesville, VA).
CRA-specific IgE was measured by coating ELISA
plates with CRA (Greer Labs) over-night at 4°C. Plates
were washed and non-specific binding blocked for
2.5 hours at room temperature on an orbital shaker.
Plates were washed an incubated with 1:10 dilutions of
plasma overnight at 4°C. Plates were washed and incu-
bated with HRP-goat anti mouse IgE for 1 hour at room
temperature on an orbital shaker. Plates were developed
using 3,3’,5,5’-Tetramethylbenzidine as substrate and
read as previously described [12]. Results are represented
as ΔOD (OD465 -O D 590). Since CRA-specific IgE stan-
dards are not currently available, plasma from a naïve
mouse was run in parallel in each assay for baseline.
Cysteinyl-Leukotriene Immunoassay
Cysteinyl leukotrienes in the BAL fluid were measured
by an Enzyme-linked Immunoassay Kit (Cayman Chemi-
cals, Ann Arbor, MI) according to the manufacturer
instructions. All samples were run at two dilutions. %B/
B0 values in the linear range of the standard curve were
accepted. Sample values that did not fall in this range
were appropriately diluted and rerun.
Statistical Analysis
All data are represented as mean ± SEM. Statistical sig-
nificance was determined by unpaired Student’s t-test or
One-way ANOVA with Turkey’sp o s tt e s tu s i n gG r a p h -
Pad Prism version 4.0.3. (GraphPad Software, San Diego,
CA). Statistical significance was achieved when p < 0.05.
Results
Depletion of LPS from the house dust extract
Dust was collected from the homes of asthmatic chil-
dren as described previously [11]. This dust was shown
to contain significantly higher concentrations of cock-
roach allergens Bla g1 and Bla g2 in comparison to
other indoor and outdoor allergens [12]. This extract,
when used in previous studies at a 1:10 dilution (con-
taining a total of 61.9 ng CRA) successfully induced the
hallmark features of asthma-like inflammation, including
airways hyperresponsiveness, eosinophilia and plasma
IgE [18-20]. In the present study, we specifically sought
to determine whether removal of the potent innate
immune activating agent LPS from the HDE at the time
of allergen challenge would attenuate the severity of pul-
monary inflammation in sensitized mice. To address this
question, LPS in the HDE was reduced as described in
materials and methods. Unfortunately, our previous
attempts at LPS removal using polymyxin B columns
(Pierce, Rockford, IL) also removed 99.9% of Bla g1
from the HDE, and these preparations were not appro-
priate for the present studies (Table 1). Although use of
the EndoTrap column in this study slightly reduced
CRA concentrations, through appropriate dilution, we
were able to maintain the same total amount of 61.9 ng
CRA for all treatments (Table 2).
TNFa production in BAL fluid post final challenge
Sensitization to cockroach allergens plays a key role in
the development of childhood asthma [21], and the level
of LPS present in the home has also been shown to
have a major effect on the severity of respiratory dis-
eases [5,10,22]. Asthma-like inflammation was induced
by i.p. immunization with 61.9 ng CRA, containing
11.6 ng of LPS. Mice were challenged on days 14 and
21 with either the intact HDE (182.1 ng of LPS) or
LPS-reduced HDE (3.0 ng of LPS). Although different
allergen mixtures are used for sensitization and chal-
lenge, we have previously shown that HDE immuniza-
tion specifically induces an allergic response to CRA
[12]. Consistent with the low levels of LPS present in
the LPS-reduced HDE, TNFa production was signifi-
cantly decreased in this gro u pa t2h o u r sp o s tf i n a l
challenge (Figure 1). We have previously shown that
this early timepoint reflects the point at which TNFa
production peaks in the BAL fluid [19].
Role of LPS in antibody production
T h ep r e s e n c eo ra b s e n c eo fT N F a has been shown to
affect the antibody response to allergen [8]. We sought
to determine whether the reduced levels of TNFa pro-
duced in response to challenge with the LPS-reduced
HDE had an effect on antibody production in this
model. Intact HDE challenge resulted in robust IgE pro-
duction while challenge with LPS-reduced HDE did not
Table 1 Total amounts of CRA and LPS in the intact HDE
and in the HDE treated with Polymyxin B or EndoTrap to
deplete LPS
Bla g1 (ng/ml) Bla g2 (ng/ml) LPS (ng/ml)
Intact HDE 4,938 11,710 18.2
After Polymyxin
B Column
1.4 6,400 1.0
After Endotrap
Column
2,058 6,113 1.7
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ing only the CRA immunization (Figure 2A). Despite
the global increase in IgE, measurement of CRA-specific
IgE showed no difference between LPS-reduced HDE
challenge and HDE challenge (Figure 2B). IgG1 produc-
tion was similar to total IgE production with reduced
levels in the mice challenged with the LPS-reduced
HDE compared to immunized-only mice (Figure 2C).
These changes in immunoglobulins were not found with
all classes, since LPS-reduced HDE challenge induced
significantly higher levels of plasma IgG2a compared to
the immunized-only group (Figure 2D).
Inflammatory cell recruitment in the BAL fluid post
allergen challenge
The composition of inflammatory cells in the BAL fluid
was assessed at various timepoints after the final intratra-
cheal challenge. Cytospin preparations demonstrate distinct
inflammatory cell morphology. Eosinophils were character-
ized by a ring-shaped nucleus with pink cytoplasmic
amyloid staining, while neutrophils show a lobular nucleus
with no cytoplasmic staining. Similar numbers of eosino-
phils and neutrophils in the mice challenged with the intact
HDE or the LPS-reduced HDE, in contrast to that of naïve
mice containing predominantly macrophages (Figure 3).
We observed a slight reduction in eosinophil numbers in
the BAL fluid of the LPS-reduced HDE group, but this
change did not reach statistical significance (Figure 4A). In
the BAL fluid, the eosinophil-specific chemoattractant
eotaxin-1 (CCL11) was significantly increased at 24 hours
post final challenge in the LPS-reduced HDE mice, however
no difference in eotaxin-2 (CCL24) was observed (Figure 4).
We also assayed eosinophil-specific peroxidase activity
(EPO) in the lungs of mice (after BAL) as a measure of
eosinophils within the lung interstitium. No significant dif-
ference in EPO was measured between the two groups
(Figure 4D). A statistically significant decrease in eotaxin-1
(CCL11) was measured in the lung homogenate of the
LPS-reduced HDE group (Figure 4E), but no difference
was measured in eotaxin-2 (CCL24) between groups
(Figure 4F). While statistically significant differences in
eotaxin-1 are observed in both the BAL and lung homoge-
nate, it should be noted that eotaxin-2 is produced at
much higher concentrations in both the alveolar compart-
ment and the lung tissue, rendering an equivalent bio-
logical outcome (eosinophil recruitment) in both groups.
We also assayed the number of neutrophils recruited
in response to allergen challenge. Interestingly, compar-
able numbers of neutrophils were present in both
Table 2 Amounts of CRA and LPS present in both the
immunization and challenge mixtures
Procedure Reagent Total CRA
(ng/dose)
LPS
(ng/dose)
Immunization Commercial CRA 61.9 11.6
Challenge LPS-reduced HDE 61.9 3.0
Challenge HDE 61.9 182.1
TNFD
0 2 24
0
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10000
15000
20000
25000
LPS-reduced HDE
HDE
p
g
/
m
l
***
hours post final challenge
Figure 1 TNFa production in bronchoalveolar lavage fluid.T N F a was measured by ELISA at the timepoints indicated. The 0 h sample was
collected prior to the second pulmonary challenge. Data are represented as the mean ± SEM, in some data points the symbol is larger than the
SEM. Experiments were done a minimum of 3 times with 3-4 mice per group, per experiment. ***p ≤ 0.0001 comparing the LPS-reduced HDE
group to the HDE group by Student’s t-test.
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HDE (Figure 5A). This suggests that other components
o ft h eH D Ea r ea b l et oa c t i v a t et h ei n n a t ei m m u n e
response in order to recruit neutrophils. The concentra-
tions of the neutrophil chemoattractants CXCL1 and
CXCL2 were assayed as the mechanism of neutrophil
recruitment into the alveolar space and lung tissue. BAL
levels of CXCL1 are significantly decreased at 2 hours in
mice challenged with the LPS-reduced HDE, however
no difference was seen in CXCL2 (Figure 5). Despite
this slight decrease in chemokine production, we postu-
late that the concentrations at which they are being pro-
duced is adequate to recruit equivalent numbers of
neutrophils shown in Figure 5A.
Myeloperoxidase activity (MPO) in the lung tissue was
not changed between groups. (Figure 5D). Significant
increases were measured in both CXCL1 and CXCL2 in
the lung homogenate in the LPS-depleted HDE at all
timepoints assayed (Figure 5E). This again suggests that
although the chemokines were lower in the intact HDE,
the concentrations were sufficient to sequester neutro-
phils within the lung interstitium. No differences in
macrophage or lymphocyte numbers were seen in the
BAL and no difference was seen in neutrophil numbers
at 2 h post final challenge (data not shown).
Induction of airways hyperresponsiveness after allergen
challenge
Several studies have shown that both LPS inhalation and
pulmonary TNFa administration induce AHR, however
little data exist regarding the synergistic role of allergen
and endotoxin on AHR [23-25]. Therefore, we sought to
determine whether the levels of LPS in the HDE would
affect AHR severity. Challenge with increasing concentra-
tions of aerosolized methacholine 4 hours post final chal-
lenge did not result in any difference in AHR between
Figure 2 Plasma antibody levels in immunized and challenged mice. Plasma levels of A) IgE, B) CRA-specific IgE, C) IgG1, and D) IgG2a were
measured by standard ELISA from EDTA-plasma collected 24 hours post final challenge (day 22). The immunized-only group was sensitized on
Day 0 and plasma was collected on day 22. Data are represented as the mean ± SEM. Statistical significance was assessed by one-way ANOVA
followed by Turkey’s post test as indicated in each panel. Experiments were done a minimum of 3 times with 3-4 mice per group, per
experiment. ** p < 0.001.
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based on observations in our laboratory showing robust
AHR induction at this timepoint. No increase in AHR
was measured comparing normal mice and sensitized-
only mice (data not shown). Given the controversy
associated with non-invasive whole body plethysmogra-
phy for assessing AHR, we confirmed our findings using
invasive lung function tests. As shown in Figure 6B, inva-
sive tests demonstrated no significant difference in airway
resistance between groups at all methacholine concentra-
tions tested. We also assessed BAL cysteinyl leukotriene
(Cys-LT) concentrations at 2 hours as a mechanism for
AHR, and found no significant change in BAL Cys-LT in
mice challenged with LPS-reduced HDE compared to
HDE challenge (Figure 6C).
Th1 and Th2 cytokine production in the BAL post
allergen challenge
It has been suggested previously that the presence of
TNFa can induce increased levels of Th2 cytokines in
the BAL fluid of allergen challenged mice [19]. Further,
asthma is largely characterized as a Th2 mediated dis-
ease, accompanied by high IL-4 and IL-5 production
and low IFNg [26]. To determine whether the reduction
in TNFa seen in LPS-reduced HDE challenged mice
affected cytokine production, we assayed both Th1 and
Th2 cytokines 24 hours post final challenge. In conflict
with the Th2 paradigm, IFNg gamma was significantly
increased in the LPS-reduced HDE mice (Figure 7A).
Surprisingly, IL-5 and IL-13 were significantly increased
in the BAL from LPS-reduced HDE challenged mice
although there was no difference in IL-4 levels (Figure
7B, C). IL-17 has also been implicated as a key cytokine
in the asthmatic response, and is also modulated by LPS
levels [27,28]. However, we measured no significant dif-
ferences in IL-17 levels between groups in the BAL fluid
(data not shown).
Discussion
The effect of exposure to household dust on the devel-
opment of atopy and asthma has recently become a
focus of investigation; however this avenue of study has
resulted in more controversy than consensus. Epidemio-
logical evidence shows that the presence of cockroach
allergens in inner city homes is a strong risk factor for
the development of atopic disease [29,30]. Cockroach
allergen sensitization was found to be responsible for
exacerbations in a large proportion of asthmatic children
in inner city Washington, D.C [21]. Further, asthma
exacerbations were not the result of sensitization to
other allergens such as cat dander and dust mite aller-
gens, which were also present in these homes [1,21].
Exposure to innate immune activators such as TLR
ligands, as well as environmental pollutants such as die-
sel particulates can also drive the adaptive immune
response toward tolerance or sensitization [10,31]. This
area of study is gaining significant interest in light of the
increasing incidence of atopy and allergy in the devel-
oped world.
 
Figure 3 Cytospin preparations of cells recovered from BAL
fluid. A) Naïve mice, B) HDE challenged mice and C) LPS-reduced
HDE challenged mice at 24 hours post final challenge. Each is
represented at 1000×. Representative eosinophils (Eo) and
neutrophils (Ne) are indicated in the figure.
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Page 7 of 13This study sought to examine whether the presence of
LPS in the household environment modifies the allergic
response after sensitization to cockroach allergens has
been established. It is possible that our method of LPS
reduction also removed other allergens from the HDE
mixture which may contribute to the allergic response.
While this is a real concern, it is a shortcoming of all
column purification methods. We are confident that our
methods resulted in physiologically relevant data given
that the LPS-reduced HDE was still able to induce a
robust adaptive immune response.
Recent studies have employed house dust extracts to
determine their roles in asthma severity, and have sug-
gested that these extracts can induce allergic phenotypes
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Figure 4 Eosinophil recruitment and production of eosinophil-specific chemokines in response to allergen challenge.C y t o s p i n
preparations from cells collected in the BAL fluid at the timepoints indicated were made and 300 cell differential counts performed to
determine the absolute numbers of eosinophils (A). Concentrations of the chemokines B) CCL11 and C) CCL24 in the BAL fluid were measured
by ELISA. D) Eosinophil peroxidase activity was measured in the lung tissue after BAL at 24 hours post final challenge. Concentrations of
E) CCL11 and F) CCL24 in the lung homogenate were assayed by ELISA. Data are represented as the mean ± SEM. Experiments were done a
minimum of 3 times with 3-4 mice per group, per experiment, in some data points the symbol is larger than the SEM. * p < 0.05 and
*** p ≤ 0.0001 HDE vs. LPS-reduced HDE by Student’s t-test.
Natarajan et al. BMC Pulmonary Medicine 2011, 11:12
http://www.biomedcentral.com/1471-2466/11/12
Page 8 of 13or can skew towards tolerance, depending upon the
dose and timing of the exposure [31,32]. However, these
studies focused on the immunomodulatory effects of the
house dust extracts on mice presensitized to ovalbumin,
and thus study house dust as an exacerbating factor,
rather than a causative agent. In contrast, the current
study directly examines the synergistic effects of CRA
and LPS contained in the HDE in mice presensitized to
CRA, which is the major allergen in the HDE.
LPS contamination in allergen preparations has been
raised as an issue in many models of allergy, however
we believe that approaching these studies using house-
hold components with naturally occurring LPS more
closely and accurately reflects the environment in which
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Figure 5 Neutrophil recruitment and production of neutrophil-specific chemokines in response to allergen challenge.C y t o s p i n
preparations from cells collected in the BAL fluid at 24 hours post final challenge were made and 300 cell differential counts performed to
determine the absolute numbers of A) neutrophils. Concentrations of chemokines B) CXCL1 and C) CXCL2 in the BAL fluid were measured by
ELISA. D) Myeloperoxidase activity was measured in the lung tissue after BAL at 24 hours post final challenge. Concentrations of E) CXCL1 and
F) CXCL2 in the lung homogenate were assayed by standard ELISA. Data are represented as the mean ± SEM, in some data points the symbol is
larger than the SEM. Experiments were done a minimum of 3 times with 3-4 mice per group, per experiment. * p < 0.05, ** p ≤ 0.001 and
*** p ≤ 0.0001 comparing the LPS-reduced HDE group to HDE the group by Student’s t-test.
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Page 9 of 13Figure 6 Airways hyperresponsiveness, airway resistance and cysteinyl leukotrienes post allergen challenge. A) For non-invasive
measurement of AHR, mice were challenged with increasing concentrations of aerosolized methacholine at 4 hours after the final challenge and
PenH values are represented as percent above baseline. B) For invasive measurements, mice were challenged with methacholine and pulmonary
resistance is expressed as R cmH2O.s/mL. C) Cysteinyl leukotriene concentrations were measured in the BAL fluid 2 hours post final challenge.
Data are represented as the mean ± SEM, in some data points the symbol is larger than the SEM. Experiments were done a minimum of 3 times
with 3-4 mice per group, per experiment.
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Page 10 of 13one develops asthma. It is not appropriate to refer to
the HDE as “contaminated” with LPS, similar to how
one would not say it is contaminated with cockroach
allergens. In an OVA study, Watanabe et.al. demon-
strated that LPS contamination of commercially avail-
able OVA preparations significantly attenuated cellular
influx, AHR and IgE production [33]. The differences
observed between these models might be explained by
the intrinsic protease activity of the cockroach allergen
Bla g2, which may enhance allergen sensitization by
increasing epithelial permeability, and allergen exposure
to dendritic cells [34,35]. This highlights the need to
study the effect of LPS in the development of asthma-
like inflammation using a relevant allergen mixture.
In the lung, TNFa is primarily produced by alveolar
macrophages and secreted within 1 hour of LPS chal-
lenge [36,37]. Our results show that mice challenged
with the LPS-reduced HDE produce significantly less
TNFa compared to those challenged with the HDE, ver-
ifying that removal of LPS from the HDE has the
expected immunological effect. Several studies have
implicated TNFa and TNFa signaling in the develop-
ment of adaptive immunity, particularly in the context
of class switch to IgE production [8,9]. Therefore, we
w o u l de x p e c tt h a tw ed i dn o ts e ed i f f e r e n c e si nC R A -
specific IgE, given that our study focused on the effect
of LPS at challenge only. In contrast, the studies by
Eisenbarth et. al. and Watanabe et.al. focused on LPS at
the time of sensitization, which likely has more effect on
the production of antigen-specific antibodies [8,33]. This
was also demonstrated in a rat model where aerosol
exposure to LPS before or shortly after sensitization
reduced the development of OVA-specific IgE [22].
Levels of CRA-specific IgG1 and IgG2a are of significant
interest, however reliable assays for these antibodies are
not currently available.
T h ei n c r e a s ei nt o t a lI g Ea n dI g G 1i nt h eH D E -
challenged mice represents an increase in polyclonal, anti-
gen non-specific IgE. LPS alone has been shown to induce
expression of activation-induced cytidine deaminase,
which is required for activation of downstream signals
responsible for class switch recombination to both IgG1
and IgE in B cells [38]. Other models have shown polyclo-
nal IgE to have a role in mast cell survival and cytokine
release [39].
Our data demonstrate that airways hyperresponsive-
ness was not diminished in the LPS-reduced HDE chal-
lenged groups despite significantly attenuated TNFa.
We postulate that AHR is governed by other mediators
and is not directly induced by TNFa.T h er o l eo fI g E
was explored in other studies that demonstrated that
AHR may be modified independent of IgE alterations.
Hamelmann et. al. showed robust AHR induction in
both mast cell and B cell deficient mice and it has been
Figure 7 Th1 and Th2 cytokine production in the BAL fluid at 24 hours post final challenge. Cytokines were assayed by standard ELISA.
Data are represented as the mean ± SEM. Experiments were done a minimum of 3 times with 3-4 mice per group, per experiment. * p < 0.05
and *** p ≤ 0.0001 comparing the LPS-reduced HDE to HDE the group by Student’s t-test.
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Page 11 of 13shown that mast cell activation is not required for the
induction of AHR [40,41]. Further, methacholine acts
directly upon muscarinic receptors in order to induce
smooth muscle contraction. We have recently shown
that pulmonary exposure to high concentrations of LPS
can induce modest differences in muscarinic receptor
expression [42]. Therefore, it is possible that the con-
centrations of LPS used in this study were not sufficient
to alter muscarinic receptor expression, and therefore
did not alter AHR.
The role of LPS in driving allergic responses toward a
Th2 phenotype has been demonstrated in several models
and our data show this to be true in the context of total
antibody production. However, our data show increases
in both Th1 and Th2 cytokines in the LPS-reduced HDE
group. One possible explanation for this is that the
source of these cytokines is not only the T cells present
in the lung. Other cell types such as eosinophils, epithe-
lial cells and mast cells are contributing to the pool of
cytokines present in the BAL fluid [43]. Therefore, with-
out assessing the direct cellular source of these cytokines,
it is not possible to conclude whether LPS-induced Th2
cell differentiation is impaired in this model.
Interestingly, challenge with intact HDE results in
decreased BAL cytokine production. We postulate that
this is modulation of the innate immune response
through induction of microbial cross-tolerance. We and
others have shown that cross-tolerance to TLR ligands
can be induced in the lung and in pulmonary macro-
phages [44,45]. It is likely that simultaneous exposure to
various TLR ligands present in the HDE can induce
cross-tolerance and therefore attenuate the cytokine
response. Removal of the potent TLR4 agonist LPS, may
reduce the tolerogenic response, driving increased cyto-
kine production.
Limited epidemiological data exist investigating
whether removal of house dust can limit future asthma
exacerbations. One such study carried out in the UK
found no correlation between removal of house dust
and amelioration of asthma symptoms in presensitized
individuals. However, interventions to reduce dust in
homes of children who were highly susceptible to devel-
oping atopy was effective in reducing asthma diagnosis
[46,47]. Taken together our data show that in a clinically
relevant model of house dust induced asthma-like
inflammation, the removal of only LPS at challenge does
not protect against the development of the inflammatory
response. Further studies will be needed to clarify
whether LPS in the home environment exacerbates
asthma in presensitized individuals.
Conclusions
Decreasing the endotoxin content endogenously present in
cockroach allergens results in a complicated pulmonary
inflammatory response. While there was differential regu-
lation of cytokine, chemokines and plasma levels of immu-
noglobulins, there was no real change in AHR or
pulmonary inflammatory cell recruitment.
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